| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |